Front-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Docetaxel and Gemcitabine: A Multicenter Phase II Trial - Concepedia

Concepedia

Publication | Closed Access

Front-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Docetaxel and Gemcitabine: A Multicenter Phase II Trial

128

Citations

44

References

1999

Year

Vassilis Georgoulias, Charalambos Kouroussis, N. Androulakis, S. Kakolyris, Meletios Α. Dimopoulos, E. Papadakis, Demosthenes Bouros, F Apostolopoulou, Christos Papadimitriou, Athina Agelidou,

Journal of Clinical Oncology

Abstract

The combination of docetaxel/gemcitabine is well tolerated, can be used for outpatients, and is active for the treatment of advanced NSCLC. This treatment merits further comparison with other cisplatin- or carboplatin-based combinations.

References

	Year	Citations

Page 1